Zika Virus Testing Market to Grow with a CAGR of 6.42% through 2028
Growing prevalence of viral diseases are expected to
drive the Global Zika Virus Testing Market in the forecast period 2024-2028.
According to TechSci Research report, “Zika Virus
Testing Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Global Zika Virus Testing Market stood at USD
162.23 million in 2022 and is anticipated to grow with a CAGR of 6.42% in the
forecast period, 2024-2028. Factors driving market growth include the
increasing incidence of Zika virus infection and advancements in Zika virus
testing technologies. According to data from the World Health Organization
(WHO) as of October 2022, Zika virus infection has been identified as endemic
in regions such as Africa and Southeast Asia. Consequently, the virus has
spread across the Pacific region, causing outbreaks in both developed and emerging
nations. Notably, major Zika virus outbreaks have occurred in Asia-Pacific
countries, particularly India, and South American nations. Additionally, as of
February 2022, WHO data indicated that Zika transmission persisted in several
countries but generally at lower levels through 2021. This growing prevalence
of Zika virus infection stands as a primary driver of market growth.
Other notable market drivers encompass increased
research and development efforts by biopharmaceutical companies and
technological advancements in diagnostic tests. Furthermore, governments
worldwide are placing greater emphasis on initiatives aimed at curbing Zika
virus transmission, further propelling market expansion. For instance, in May
2022, the government of Uttar Pradesh in India launched the 'Zero Mission'
campaign to eradicate vector-borne diseases, including Japanese encephalitis,
dengue, malaria, typhoid, pneumonia, and Zika virus. Consequently, the global
rise in Zika virus infection rates and government-driven initiatives stand as
principal factors fueling market growth in the foreseeable future.
Nevertheless, the high cost of testing kits is anticipated to act as a
deterrent to market growth during the forecast period.
Zika virus is a single-stranded RNA virus belonging to
the Flaviviridae family, which also includes other well-known viruses like
dengue, West Nile, and yellow fever viruses. The Zika virus is primarily
transmitted to humans through the bite of infected Aedes mosquitoes,
particularly Aedes aegypti and Aedes albopictus. Key characteristics and
information about Zika virus include: Transmission: The primary mode of Zika
virus transmission is through the bite of infected mosquitoes. However, it can
also be transmitted through sexual contact, from mother to child during
pregnancy, and through blood transfusions or organ transplants. Symptoms: Many
Zika virus infections are asymptomatic, meaning infected individuals do not
show any symptoms. When symptoms do occur, they are usually mild and include
fever, rash, joint pain, muscle pain, headache, and conjunctivitis (red eyes).
These symptoms typically last for a few days to a week. Complications: Zika
virus gained significant attention due to its association with severe birth
defects when pregnant women are infected, particularly microcephaly (an
abnormally small head and brain) in newborns. It has also been linked to
Guillain-Barré syndrome, a rare neurological disorder. Geographic Distribution:
Zika virus was originally identified in Uganda in 1947 and was relatively rare
in humans until a significant outbreak in the Pacific Islands in 2007.
Subsequent outbreaks occurred in various regions, including South and Central America,
the Caribbean, and Southeast Asia. Prevention: Preventing Zika virus infection
primarily involves mosquito control measures, such as using insect repellent,
wearing long-sleeved clothing, and eliminating standing water where mosquitoes
breed. Safe sexual practices are recommended to reduce the risk of sexual
transmission. Vaccination: As of my last knowledge update in September 2021,
there was no specific vaccine available for Zika virus. However, research and
development efforts were ongoing. Travel Advisories: Travelers to regions with
active Zika virus transmission are advised to take precautions to avoid
mosquito bites and, if necessary, to practice safe sex to prevent sexual
transmission. It's important to note that the understanding of Zika virus may
have evolved since my last update, and new information may have become available
regarding its transmission, prevention, and potential vaccines. It is advisable
to refer to updated and reliable sources, such as the World Health Organization
(WHO) or the Centers for Disease Control and Prevention (CDC), for the latest
information on Zika virus.
.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global
Zika Virus Testing Market.’’
The Global Zika Virus Testing Market is influenced by
several key drivers: Prevalence and Outbreaks: The occurrence of Zika virus
outbreaks in various regions around the world drives the demand for Zika virus
testing. These outbreaks highlight the need for early detection and monitoring
of the virus, especially in areas prone to mosquito-borne diseases. Pregnancy
Monitoring: Due to the association between Zika virus infection during
pregnancy and severe birth defects like microcephaly, routine testing of pregnant
women in affected regions is essential. This emphasis on pregnancy monitoring
fuels the demand for Zika virus testing. International Travel: Global travel
contributes to the potential spread of Zika virus, as individuals may visit
destinations where the virus is actively circulating. This leads to increased
demand for testing among travelers returning from affected areas. Technological
Advancements: Ongoing advancements in diagnostic technologies, including
molecular assays and serological tests, improve the accuracy and efficiency of
Zika virus testing, making it more accessible and reliable. Government
Initiatives: Government healthcare agencies and international organizations
often support testing programs during outbreaks to control the spread of the
virus. These initiatives play a crucial role in driving market demand. Research
and Development: Research efforts to develop new and improved diagnostic tools,
treatments, and vaccines for Zika virus contribute to the growth of the testing
market. This includes the development of rapid diagnostic tests and innovative
testing methods. Regulatory Approvals: Stringent regulatory guidelines and
approvals for Zika virus testing kits ensure their accuracy and reliability,
instilling confidence in healthcare providers and patients. Public Awareness
Campaigns: Public awareness campaigns and education programs about Zika virus
and the importance of testing contribute to increased testing rates, especially
among high-risk populations. Global Health Concerns: Zika virus testing is part
of the global effort to monitor and control infectious diseases, making it a
priority for healthcare systems and organizations worldwide. These drivers
collectively contribute to the growth and development of the Global Zika Virus
Testing Market, ensuring that accurate and efficient testing methods are
available to healthcare providers and authorities, ultimately aiding in
outbreak control and prevention efforts.
The Global Zika Virus Testing Market is segmented into
test type, regional distribution, and company. Based on tests type, the market
is segmented Nucleic Acid Amplification Testing (NAAT), Serological Testing.
The growth hormone deficiency segment is expected to rise in the forecast
period. both tests were performed on the majority of subjects, to confirm ZIKV
infection. However, the NAAT segment edged over by a small margin as it is more
widely available and can be used for large scale surveillance with
cost-effectiveness. Later on, serological diagnostics started gaining
preference to NAAT as they can detect acute as well as late-stage ZIKV
infection. In addition, emerging rapid detection serological diagnostics offer
shorter turnaround time as well as differential diagnosis of Zika against other
flaviviruses.Based on region, the market is segmented into North America, Europe,
Asia Pacific, Central & South America, Middle East & Africa. The North
America segment was dominated the market in 2022. This is the because the U.S.
states and territories dominated the market. Since the outbreak, the U.S. has
developed a national response framework to prevent virus spread across the
country by collaborating with organizations, such as the CDC, WHO, and PAHO.
The country-wide mandate that was passed in 2016, requiring all donated blood
to undergo individual donor-NAAT screening for Zika virus is the underlying
factor contributing to the growth of the regional market.
Major companies operating in Global
Zika Virus Testing Market are:
- Quest Diagnostics, Inc.
- Chembio Diagnostic Systems, Inc.
- Roche
- Biocan Diagnostics, Inc.
- Euroimmun
- Altona Diagnostics
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Zika Virus Testing Market is driven by
several key factors. The prevalence of Zika virus outbreaks in different
regions fuels demand for early detection and monitoring. Routine testing of
pregnant women in affected areas is essential due to the virus's link with
severe birth defects. International travel leads to increased testing among
travelers returning from Zika-affected regions. Ongoing technological
advancements improve test accuracy and accessibility. Government initiatives,
research, and development efforts, stringent regulatory approvals, public
awareness campaigns, and global health concerns further boost the market. These
drivers collectively support the availability and use of Zika virus testing,
aiding in outbreak control and prevention contributes to foster the demand for Global
Zika Virus Testing Market in the forecast period” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Zika Virus Testing Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
Segmented By Test Type (Nucleic Acid Amplification Testing (NAAT), Serological
Testing), By Region and Competition.” has evaluated
the future growth potential of Global Zika Virus Testing Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Zika Virus Testing Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website:
https://www.techsciresearch.com